Cleared Traditional

K142459 - Ebony PTA 0.014 RX Peripheral Dilatation Catheter

K142459 is an FDA 510(k) clearance for Ebony PTA 0.014 RX Peripheral Dilatatio..., manufactured by Natec Medical , Ltd.. The device is a Class 2 Cardiovascular device with product code LIT cleared through the Traditional 510(k) pathway after a 154-day FDA review.

K142459 · Natec Medical , Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2015
Decision
154d
Days
Class 2
Risk

K142459 is an FDA 510(k) clearance for the Ebony PTA 0.014 RX Peripheral Dilatation Catheter. Classified as Catheter, Angioplasty, Peripheral, Transluminal (product code LIT), Class II - Special Controls.

Submitted by Natec Medical , Ltd. (Reduit, MU). The FDA issued a Cleared decision on February 3, 2015 after a review of 154 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Natec Medical , Ltd. devices

FDA 510(k) Submission Details - K142459

510(k) Number K142459 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 02, 2014
Decision Date February 03, 2015
Days to Decision 154 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
29d slower than avg
Panel avg: 125d · This submission: 154d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LIT Device Classification - Class 2, Special Controls

Product Code LIT Catheter, Angioplasty, Peripheral, Transluminal
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

CardioMed Device Consultants, LLC
Judith Danielson

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LIT Catheter, Angioplasty, Peripheral, Transluminal

All 368
Devices cleared under the same product code (LIT) and FDA review panel - the closest regulatory comparables to K142459.
FLASH Ostial System OTW-6.0mm x 12mm x 80cm, FLASH Ostial System OTW-6.0mm x 12mm x 135cm, FLASH Ostial System OTW-7.0mm x 12mm x 80cm, FLASH Ostial System OTW-7.0mm x 12mm x 135cm
K150946 · Ostial Corporation · May 2015
Ebony PTA 0.035 Peripheral Dilatation Catheter
K143036 · Natec Medical , Ltd. · Mar 2015
Vector PTA Balloon Dilatation Catheter
K143652 · Vector Corporation, LLC · Feb 2015
Passeo-35 PTA Catheter
K142379 · Biotronik, Inc. · Dec 2014
Fortrex 0.035 OTW PTA Balloon Catheter
K142654 · Covidien, LLC · Oct 2014
PTA BALLOON DILATATION CATHETER
K141150 · Boston Scientific Corp · Sep 2014